
Angion Biomedica Corp. ANGN
Quarterly report 2025-Q3
added 11-13-2025
Country |
|
IPO year |
2021 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
12.2 M |
Market Cap[1] |
$ 30.1 M |
EBITDA (LTM) |
$ -39.4 M |
P/E (LTM) |
- |
P/S (LTM) |
7.0 |
EPS (LTM) |
-3.52 |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.